CIA
CELL

Capital Impact Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Capital Impact Advisors’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-53,808
Closed -$26.4K – 174
2023
Q2 		$26.4K Hold
53,808
– – 0.03% 174
2023
Q1 		$62.4K Buy
53,808
+32,003
+147% +$58.5K 0.08% 173
2022
Q4 		$58.4K Hold
21,805
– – 0.06% 232
2022
Q3 		$65K Buy
+21,805
New +$92.7K 0.06% 229
2021
Q1 		– Sell
-9,100
Closed -$814K – 142
2020
Q4 		$814K Buy
+9,100
New +$765K 0.2% 102

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Impact Advisors's CELL Position: Q3 2023 in Review

Capital Impact Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 53,808 shares — an estimated $26.4K sold.

Capital Impact Advisors first reported a position in CELL in Q4 2020 and held it in 5 quarters. The position peaked at $814K in Q4 2020. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Capital Impact Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Capital Impact Advisors sold 53,808 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $26.4K.
  • Capital Impact Advisors first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Capital Impact Advisors's PhenomeX Inc. Common Stock position peaked at $814K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Capital Impact Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.